After hospital work, Van-Tam was involved variously as a university lecturer and within the pharmaceutical industry. Van-Tam became a Deputy Chief Medical Officer for England on 2 October 2017. He played a very significant part in the UK's response to the Covid-19 pandemic which started in 2020[6] as one of two deputies.[7] In May 2023 he joined Covid-19 vaccine maker Moderna as a consultant.[8]
After five years of hospital-based clinical medicine, Van-Tam pursued academic training in public health and epidemiology and developed an interest in influenza and respiratory viruses, mentored for many years by Professor Karl Nicholson. He became a senior lecturer at the University of Nottingham (and consultant regional epidemiologist, Public Health Laboratory Service) in 1997,[15] before joining the pharmaceutical industry as an associate director at SmithKline Beecham in 2000.
In April 2001 he moved to Roche as head of medical affairs, before joining Aventis Pasteur MSD in February 2002 as UK medical director.
Van-Tam returned to the public sector in 2004 at the Health Protection Agency Centre for Infections, where he was head of the pandemic influenza office until October 2007. He then returned to Nottingham as professor of health protection. He has published over 100 scientific papers and written four textbooks. He chaired the European Centre for Disease Prevention and Control (ECDC) Expert Advisory Group on H5N1 human vaccines, sits on the UK national Scientific Pandemic Influenza Committee (SPI), and was a member of the UK Scientific Advisory Group for Emergencies (SAGE) during the 2009-10 pandemic. He is co-editor of the textbook Introduction to Pandemic Influenza[16] and was editor-in-chief of the journal Influenza and Other Respiratory Viruses from 2014 to 2017.[17]
His unit is an officially designated WHO Collaborating Centre for pandemic influenza and research and a UK Faculty of Public Health "National Treasure" research training location.
On 2 October 2017, he took up the role of deputy chief medical officer for England.[18] In this capacity, he gained nationwide visibility during the 2020 COVID-19 pandemic.[19][20] In May 2020, he was appointed to the expert advisory group for the UK Government's Vaccine Taskforce, chaired by Patrick Vallance.[21]
It was announced in January 2022 that Van-Tam would step down from the role of deputy chief medical officer for England at the end of March 2022.[6] His new academic post as Faculty Pro-Vice-Chancellor for Medicine & Health Sciences at the University of Nottingham was due to start on 1 May 2022.[22]
On 2 May 2023, Van-Tam began work as a senior medical consultant to the Covid-19 vaccine maker Moderna.[8]
Awards and honours
Van-Tam was appointed Member of the Order of the British Empire (MBE) in the 1998 New Year Honours as an acting major in the Lincolnshire Army Cadet Force. It was awarded in recognition of his work in designing a medical kit to meet the special requirements of large groups of teenagers on camping expeditions. This sprang from his work with the Lincolnshire Army Cadets since 1988. His ideas were accepted by the Ministry of Defence.
On 1 December 2021 he was announced as one of the Boston Heroes along with 9 other residents of Boston out of 240 put forward by the people of his home town. In March 2022 he was awarded the Freedom of the Borough of Boston in appreciation for his work on the COVID-19 pandemic.[27][28][29][30]
In 2023, he was awarded the David Attenborough Award by The Royal Society for his 'outstanding public engagement with science' through communicating COVID-19.
Army Cadet Force (ACF)
In October 2022, Van-Tam was promoted to Honorary Colonel for Medical Support, in the Army Cadet Force (ACF).[35] Van-Tam has many years of experience working with the ACF.[36]
^ abBagley, Geo. S. (1985). Floreat Bostona, The history of Boston Grammar School from 1567. The Old Bostonian Association. p. 242. ISBN978-0951043103.
^The Medical Directory 2006/07. Vol. 2 (162 ed.). London: Informa Healthcare. 2006. p. 2443. ISBN1-843115425.